Duo-Blend Tesamorelin / Ipamorelin 8 mg
- Active Substance: Tesamorelin (6 mg) and Ipamorelin (2 mg)
- Concentration: 8 mg per vial (6 mg Tesamorelin + 2 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (Tesamorelin): C221H366N72O67S
- Molecular Weight (Tesamorelin): 5135.86 g/mol
- Sequence (Tesamorelin): Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: Tesamorelin (Egrifta, TH9507), Ipamorelin (GHRP, Ghrelin mimetic)
Duo-Blend Tesamorelin / Ipamorelin 8 mg – Vanguard of Metabolic Transformation
Product Summary
Picture a research frontier where visceral fat fades, muscles thrive, and aging slows. Duo-Blend Tesamorelin / Ipamorelin 8 mg vial from Peptide Sciences USA leads this charge. By uniting Tesamorelin's visceral fat reduction with Ipamorelin's selective GH release, this blend drives fat loss, muscle recovery, and anti-aging, offering a premier tool for pioneering health research.
How Duo-Blend Tesamorelin / Ipamorelin Works
The Duo-Blend Tesamorelin / Ipamorelin combines Tesamorelin (sequence: Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2), a growth hormone-releasing hormone (GHRH) analog, with Ipamorelin (sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2), a selective growth hormone secretagogue. Tesamorelin binds to GHRH receptors on pituitary somatotroph cells, increasing GH and IGF-1 levels by up to 181 µg/L, promoting lipolysis and reducing visceral adipose tissue (VAT) by ~20% in 12 months. Ipamorelin activates GHS-R1a receptors, inducing GH release within 2 hours without elevating cortisol or prolactin, ensuring a clean safety profile.
Their synergy delivers a 3–5-fold increase in GH release, enhancing protein synthesis, fat metabolism, and tissue repair. Preclinical studies show Tesamorelin reduces carotid intima-media thickness (cIMT), C-reactive protein (CRP), and triglycerides, while Ipamorelin supports muscle hypertrophy and recovery. This blend is ideal for researching visceral fat reduction, body composition, and anti-aging, with applications in metabolic health and cognitive function.
Why Choose Duo-Blend Tesamorelin / Ipamorelin 8 mg?
This peptide blend is a cornerstone for fat loss and anti-aging research, offering synergistic benefits with minimal side effects. Here's why it stands out:
- Visceral Fat Reduction: Tesamorelin reduces VAT by ~20% in 12 months, improving metabolic health in preclinical models.
- Muscle Growth: Boosts GH and IGF-1 levels, promoting muscle hypertrophy and protein synthesis.
- Enhanced Recovery: Speeds muscle and tissue repair, minimizing recovery time in injury models.
- Anti-Aging Benefits: Improves sleep, cognitive function, and skin elasticity, supporting longevity research.
- Unmatched Quality: Peptide Sciences USA guarantees 99% purity through advanced synthesis, ensuring reliable research outcomes.
Duo-Blend Tesamorelin / Ipamorelin 8 mg empowers researchers to propel health research, backed by cutting-edge peptide science.
Product Specifications
Peptide Sciences USA's Duo-Blend Tesamorelin / Ipamorelin 8 mg vial is crafted for precision in growth hormone research, delivering exceptional quality. Here's the breakdown:
- Composition: Contains 8 mg total (6 mg Tesamorelin, C221H366N72O67S, 5135.86 g/mol; 2 mg Ipamorelin, C38H49N9O5, 711.85 g/mol).
- Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous injection.
- Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by High-Performance Liquid Chromatography and Mass Spectrometry.
- Usage Guidelines: Reconstitute with bacteriostatic water and administer subcutaneously, typically at 1–2 mg Tesamorelin and 100–300 mcg Ipamorelin daily, ideally at night, in research protocols. Use under professional supervision.
- Storage: Store lyophilized powder at -20°C for long-term stability or 4°C for short-term use (up to 3–4 weeks). After reconstitution, refrigerate at 2–8°C and use within 30 days.
- Safety: Preclinical studies report mild side effects like injection site irritation or headaches; Ipamorelin's selectivity minimizes cortisol/prolactin effects. Limited human data requires research oversight.
This peptide blend is for research purposes only, providing a robust platform for studying growth hormone optimization and fat reduction.
Legal Disclaimer
Duo-Blend Tesamorelin / Ipamorelin 8 mg is supplied for research purposes only and is not FDA-approved for human use, though Tesamorelin is FDA-approved for HIV-associated lipodystrophy. It is banned by the World Anti-Doping Agency (WADA) for performance-enhancing use. It is not intended to diagnose, treat, cure, or prevent any condition. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical research.
Frequently Asked Questions
What is the purpose of the Duo-Blend Tesamorelin / Ipamorelin 8 mg in research?
The blend is used to study growth hormone optimization, targeting visceral fat reduction, muscle growth, recovery, and anti-aging effects in preclinical models.
What benefits does the Duo-Blend Tesamorelin / Ipamorelin 8 mg offer in studies?
It reduces visceral fat by ~20%, boosts muscle growth, enhances recovery, and improves sleep and cognitive function, ideal for fat loss and longevity research.
Are there side effects with the Duo-Blend Tesamorelin / Ipamorelin 8 mg blend?
Preclinical studies report mild injection site irritation or headaches. Ipamorelin's selectivity minimizes cortisol/prolactin effects, but oversight is needed.
How is the Duo-Blend Tesamorelin / Ipamorelin 8 mg administered in research?
The 8 mg lyophilized powder is reconstituted with bacteriostatic water and injected subcutaneously, typically at 1–2 mg Tesamorelin and 100–300 mcg Ipamorelin daily.
How should the Duo-Blend Tesamorelin / Ipamorelin 8 mg vial be stored?
Store lyophilized powder at -20°C or 4°C for up to 3–4 weeks. After reconstitution, refrigerate at 2–8°C and use within 30 days to maintain potency.
Related Products
- Active Substance: Tesamorelin
- Concentration: 5 mg per vial
- Pack Size: Lyophilized injectable vial
- Manufacturer: Dragon Pharma
- Brand Name: Tesamorelin
- Molecular Formula: C221H366N72O67S
- Molecular Weight: 5135.91 g/mol
- Synonyms: Egrifta, GHRH(1–44) analog, GHRH modulator
- Active Substance: Epitalon
- Concentration: 50 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Epitalon
- Molecular Formula: C14H22N4O9
- Molecular Weight: 390.35 g/mol
- Sequence: Ala-Glu-Asp-Gly
- Synonyms: Epithalon, AEDG, Epithalamin analog
- Active Substance: Proxofim (FOXO4-D-Retro-Inverso)
- Concentration: 10 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Proxofim
- Molecular Formula: C228H388N86O64
- Molecular Weight: 5358.05 g/mol
- Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
- Synonyms: Forkhead box protein O4 D-Retro-Inverso, FOXO4a, AFX, AFX1, MLLT7
- Active Substance: HGH Fragment 176-191 (6 mg), Modified GRF (CJC-1295 No DAC, 3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg Modified GRF + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (Modified GRF): C152H252N44O42
- Molecular Weight (Modified GRF): 3367.97 g/mol
- Sequence (Modified GRF): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), Modified GRF (CJC-1295 No DAC), Ipamorelin (GHRP, Ghrelin mimetic)
- Active Substance: HGH Fragment 176-191 (6 mg), CJC1295 No DAC (3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg CJC1295 + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (CJC1295 No DAC): C152H252N44O42
- Molecular Weight (CJC1295 No DAC): 3367.97 g/mol
- Sequence (CJC1295 No DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), CJC1295 No DAC (Mod GRF), Ipamorelin (GHRP, Ghrelin mimetic)